Abstract
The human major histocompatibility complex (MHC) contains genes encoding the Human Leukocyte Antigens (HLA). Of these antigens, placental immunologists need study only the HLA class I molecules, because HLA class II expression is repressed in the fetal placental cells that are in direct contact with maternal blood and tissues containing maternal immune cells. The class I antigens are subdivided into two general categories. The class Ia antigens are highly polymorphic and are typified by HLA-A, -B, and -C; these are expressed by nearly all somatic cells and stimulate graft rejection when foreign to the host. By contrast, the HLA class Ib antigens, HLA-E, -F, and -G, have restricted expression, few variants, and appear rarely to be immunostimulatory. One class Ia antigen, HLA-C, and the three class Ib antigens are differentially expressed by trophoblast cell subpopulations. In order to understand immune privilege in the pregnant uterus and placenta, it is essential to study the unique structural and functional features of these four genes and their glycoprotein products. In this chapter, we focus on the first class Ib gene identified in human placentas, HLA-G, with emphasis on its two soluble isoforms, HLA-G5 and HLA-G6. We describe methods developed in our laboratory to distinguish mRNAs encoding HLA-G5 and HLA-G6, and antibody-based protocols for identification of the soluble isoforms.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Janeway, C. A., Travers, P., Walport, M., and Capra, J. D. (1999) Immunobiology. Garland, New York, NY, pp. 509ā516.
Ishitani, A., Sageshima, N., Lee, N., et al. (2003) Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J. Immunol. 171, 1376ā1384.
McMaster, M. T., Librach, C. L., Zhou, Y., et al. (1995) Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J. Immunol. 154, 3771ā3778.
Hunt, J. S. and Hutter, H. (1996) Current theories on protection of the fetal semiallograft, in HLA and the Maternal-Fetal Relationship (Hunt, J. S., ed.). Landes, Austin, TX: pp. 27ā50.
Carosella, E. D., Dausset, J., and Rouas-Freiss, N. (1999) Immunotolerant functions of HLA-G. Cell Mol. Life Sci. 55, 327ā333.
Hunt, J. S. (2002) Immunogenetics: genetic regulation of immunity in pregnancy, in Reproductive Medicine: Molecular, Cellular and Genetic Fundamentals (Fauser, B. C. J. M., ed.). Parthenon, NY: pp. 153ā167.
Ishitani, A. and Geraghty, D. E. (1992) Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc. Natl. Acad. Sci. USA 89, 3947ā3951.
Paul, P., Cabestre, F. A., Ibrahim, E. C., et al. (2000) Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5,-G6,-G7 transcripts in human transfected cells. Hum. Immunol. 61, 1138ā1149.
Ober, C, Aldrich, C., Rosinsky, B., et al. (1998) HLA-G1 protein expression is not essential for fetal survival. Placenta 19, 127ā132.
Lee, N., Llano, M., Carretero, M., et al. (1998) HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 95, 5199ā5204.
Morales, P., Pace, J. L., Platt, J. S., et al. (2003) Placental cell expression of HLAG2 isoforms is limited to the invasive trophoblast phenotype. J. Immunol. 171, 6215ā6224.
McIntire, R. H., Morales, P. J., Petroff, M. G., Colonna, M., and Hunt, J. S. (2004) Recombinant HLA-G5 and-G6 drive U937 myelomonocytic cell production of TGF-Ī²1. J Leukoc Biol. 76 (6), 1220ā1228.
Fournel, S., Aguerre-Girr, M., Huc, X., et al. (2000) Soluble HLA-G1 triggers CD95/CD95 ligand-mediates apoptosis in activated CD8+ cells by interacting with CD8. J. Immunol. 164, 6100ā6104.
LeMaoult, J., Krawice-Radanne, I., Dausset, J., and Carosella, E. D. (2004) HLAG1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc. Natl. Acad. Sci. USA 101, 7064ā7069.
Chu, W., Yang, Y., Geraghty, D. E., and Hunt, J. S. (1999) Interferons enhance HLA-G mRNA and protein in transfected mouse fibroblasts. J. Reprod. Immunol. 42, 1ā15.
Jung, T., Schauer, U., Heusser, C., Neumann, C., and Rieger, S. (1993). Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods 159, 197ā207.
Hunt, J. S., Pace, J. L., Morales, P. J., and Ober, C. (2003). Immunogenicity of the soluble isoforms of HLA-G. Mol. Hum. Reprod. 9, 729ā735.
Hviid, T. V. F, Hylenius, S., RĆørbye, C., and Nielsen, L. G. (2003). HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 55, 63ā79.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Pace, J.L., Morales, P.J., Hunt, J.S., Phillips, T.A. (2006). Analysis of the Soluble Isoforms of HLA-G. In: Soares, M.J., Hunt, J.S. (eds) Placenta and Trophoblast. Methods in Molecular Medicineā¢, vol 122. Humana Press. https://doi.org/10.1385/1-59259-989-3:181
Download citation
DOI: https://doi.org/10.1385/1-59259-989-3:181
Publisher Name: Humana Press
Print ISBN: 978-1-58829-608-5
Online ISBN: 978-1-59259-989-9
eBook Packages: Springer Protocols